Ikarian Capital, LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Ikarian Capital, LLC reported 103 stock positions worth $302.2 million. Its top holding was Cidara Therapeutics (CDTX) at 7.5% of the portfolio, followed by Alnylam Pharmaceuticals (ALNY, 6.1%) and Insmed (INSM, 5.5%). Compared with Q1 2025, it opened 20 new positions, sold out of 33, added to 14 and reduced 28. The biggest buy was Cidara Therapeutics (CDTX, shares +87%) and the biggest sale Tarsus Pharmaceuticals (TARS, shares −59%).
- Most Recent 13F
- Q2 2026
- Location
- DALLAS, TX
- CIK
- 0001778253
- Portfolio Value
- $302.2M (Q2 2025)
- SEC Filing
- 0001420506-25-002181 ↗ filed Aug 14, 2025
Holdings Value
Holdings 103 stocks · $302.2M
| CDTX Cidara Therapeutics Inc. | 7.49% | 464,488 | $22.6M | Add +86.6% |
| ALNY Alnylam Pharmaceuticals Inc. | 6.11% | 56,594 | $18.5M | Add +79.1% |
| INSM Insmed Inc. | 5.45% | 163,751 | $16.5M | Add +93.1% |
| VRNA Verona Pharma Ltd. | 4.59% | 146,831 | $13.9M | Add +12.9% |
| CRNX Crinetics Pharmaceuticals Inc. | 4.12% | 433,431 | $12.5M | Reduce -17.2% |
| AKRO Akero Therapeutics Inc. | 3.88% | 220,000 | $11.7M | Reduce -10.2% |
| PRAX Praxis Precision Medicines I | 3.85% | 276,950 | $11.6M | Add +90.3% |
| APGE Apogee Therapeutics Inc. | 3.33% | 232,047 | $10.1M | New |
| PCVX Vaxcyte Inc. | 3.28% | 305,000 | $9.9M | Add +52.5% |
| ACOG Alpha Cognition Inc. | 2.83% | 917,867 | $8.6M | Reduce -5.2% |
| TARS Tarsus Pharmaceuticals Inc. | 2.63% | 196,536 | $8.0M | Reduce -59.5% |
| CYTK Cytokinetics Inc. | 2.55% | 233,464 | $7.7M | Add +55.7% |
| SRPT Sarepta Therapeutics Inc. | 2.54% | 449,087 | $7.7M | Add +165.6% |
| TGTX TG Therapeutics Inc. | 2.50% | 209,938 | $7.6M | Reduce -0.1% |
| COGT Cogent Biosciences Inc. | 2.46% | 1,035,528 | $7.4M | New |
| VRDN Viridian Therapeutics Inc. | 2.17% | 469,949 | $6.6M | Reduce -5.0% |
| ARVN Arvinas Inc. | 2.07% | 850,000 | $6.3M | Add +269.7% |
| FBRX Forte Biosciences Inc. | 2.04% | 476,443 | $6.2M | Reduce -21.8% |
| VIR Vir Biotechnology Inc. | 1.78% | 1,068,062 | $5.4M | No change |
| CPRX Catalyst Pharmaceuticals Inc. | 1.51% | 209,649 | $4.5M | Reduce -16.0% |
| DCTH Delcath Systems Inc. | 1.45% | 322,390 | $4.4M | Add +221.2% |
| JAZZ Jazz Pharmaceuticals PLC | 1.40% | 40,000 | $4.2M | New |
| CGON CG Oncology Inc. | 1.33% | 155,000 | $4.0M | New |
| STIM Neuronetics Inc. | 1.27% | 1,099,700 | $3.8M | Reduce -0.0% |
| GPCR Structure Therapeutics Inc. | 1.26% | 183,085 | $3.8M | Reduce -30.7% |
| NAMS Newamsterdam Pharma Co. NV | 1.24% | 206,800 | $3.7M | New |
| DYN Dyne Therapeutics Inc. | 1.15% | 363,837 | $3.5M | Add +1.4% |
| TECX Tectonic Therapeutic Inc. | 1.08% | 163,696 | $3.3M | Reduce -39.2% |
| MAZE Maze Therapeutics Inc. | 1.07% | 262,740 | $3.2M | Reduce -18.6% |
| JANX Janux Therapeutics Inc. | 0.99% | 129,691 | $3.0M | No change |
| FULC Fulcrum Therapeutics Inc. | 0.98% | 428,521 | $2.9M | Add +114.2% |
| ELDN Eledon Pharmaceuticals Inc. | 0.90% | 1,000,221 | $2.7M | Reduce -2.4% |
| BIIB Biogen Inc. | 0.89% | 21,516 | $2.7M | New |
| VKTX Viking Therapeutics Inc. | 0.88% | 100,000 | $2.7M | Add +100.0% |
| RLAY Relay Therapeutics Inc. | 0.85% | 743,308 | $2.6M | No change |
| ARCT Arcturus Therapeutics Holdin | 0.75% | 175,000 | $2.3M | No change |
| GERN Geron Corp. | 0.75% | 1,600,000 | $2.3M | Add +966.7% |
| KALV Kalvista Pharmaceuticals Inc. | 0.74% | 198,528 | $2.2M | New |
| KOD Kodiak Sciences Inc. | 0.74% | 599,534 | $2.2M | Reduce -7.7% |
| LXEO Lexeo Therapeutics Inc. | 0.73% | 550,029 | $2.2M | No change |
| MTSR Metsera Inc. | 0.73% | 77,316 | $2.2M | Reduce -48.5% |
| VTYX Ventyx Biosciences Inc. | 0.69% | 967,590 | $2.1M | Reduce -20.5% |
| CPIX Cumberland Pharmaceuticals | 0.66% | 595,932 | $2.0M | Reduce -19.5% |
| PRQR Proqr Therapeutics NV | 0.59% | 868,069 | $1.8M | New |
| SRRK Scholar Rock Holding Corp. | 0.58% | 49,179 | $1.7M | Reduce -79.9% |
| DRUG Bright Minds Biosciences Inc. | 0.57% | 65,431 | $1.7M | No change |
| QURE Uniqure NV | 0.55% | 119,986 | $1.7M | New |
| SLN Silence Therapeutics PLC-ADR | 0.46% | 873,568 | $1.4M | New |
| RCUS Arcus Biosciences Inc. | 0.44% | 163,363 | $1.3M | No change |
| APLS Apellis Pharmaceuticals Inc. | 0.43% | 75,000 | $1.3M | No change |
| ALEC Alector Inc. | 0.42% | 900,000 | $1.3M | Reduce -5.3% |
| NUVB Nuvation Bio Inc. | 0.40% | 619,258 | $1.2M | No change |
| VTGN Vistagen Therapeutics Inc. | 0.40% | 601,703 | $1.2M | No change |
| HELP Cybin Inc. | 0.39% | 140,475 | $1.2M | Reduce -64.6% |
| TRML Tourmaline Bio Inc. | 0.36% | 67,927 | $1.1M | No change |
| WVE Wave Life Sciences Ltd. | 0.35% | 161,137 | $1.0M | New |
| VERU Veru Inc. | 0.27% | 1,425,239 | $829K | No change |
| ORKA Oruka Therapeutics Inc. | 0.25% | 68,574 | $769K | Reduce -60.8% |
| IBB iShares Biotechnology ETF | 0.24% | 5,755 | $728K | New |
| SGMOQ Sangamo Therapeutics Inc. | 0.23% | 1,260,179 | $682K | Reduce -32.3% |
| IMUX Immunic Inc. | 0.21% | 914,170 | $638K | No change |
| INBX Inhibrx Biosciences Inc. | 0.20% | 42,122 | $601K | No change |
| IFRX Inflarx NV | 0.18% | 705,010 | $557K | New |
| KZR Kezar Life Sciences Inc. | 0.16% | 106,901 | $490K | No change |
| VYNE THERAPEUTICS INC | 0.16% | 290,000 | $479K | New |
| IBIO Ibio Inc. | 0.15% | 599,913 | $458K | No change |
| MIND MEDICINE MINDMED INC | 0.13% | 62,691 | $407K | No change |
| BIOMX INC | 0.13% | 892,976 | $402K | No change |
| LYEL Lyell Immunopharma Inc. | 0.13% | 43,799 | $387K | No change |
| NYXH Nyxoah SA | 0.13% | 50,627 | $379K | New |
| ANAB Anaptysbio Inc. | 0.12% | 15,662 | $348K | New |
| VERA Vera Therapeutics Inc. | 0.11% | 14,096 | $332K | New |
| ZYME Zymeworks Inc. | 0.10% | 25,000 | $314K | New |
| ABOS Acumen Pharmaceuticals Inc. | 0.10% | 265,769 | $308K | No change |
| IMTX Immatics NV | 0.09% | 49,396 | $266K | New |
| VIGL Vigil Neuroscience Inc. | 0.08% | 31,360 | $249K | Reduce -87.5% |
| CMMB Chemomab Therapeutics Ltd. | 0.08% | 213,052 | $247K | No change |
| ANRO Alto Neuroscience Inc. | 0.08% | 110,000 | $242K | Reduce -37.1% |
| RNAC Cartesian Therapeutics Inc. | 0.08% | 22,166 | $230K | No change |
| ANEB Anebulo Pharmaceuticals Inc. | 0.08% | 157,720 | $227K | No change |
| TERN Terns Pharmaceuticals Inc. | 0.07% | 58,491 | $218K | Reduce -81.0% |
| EVAX Evaxion A/S | 0.06% | 80,000 | $196K | No change |
| FTH Faeth Therapeutics Inc. filed as SENSEI BIOTHERAPEUTICS INC | 0.06% | 22,497 | $193K | No change |
| LYRA Lyra Therapeutics Inc. | 0.06% | 21,161 | $190K | No change |
| AETHLON MED INC | 0.06% | 153,659 | $184K | No change |
| AVTX Avalo Therapeutics Inc. | 0.06% | 35,300 | $176K | Reduce -82.3% |
| VYGR Voyager Therapeutics Inc. | 0.06% | 55,766 | $173K | No change |
| LXRX Lexicon Pharmaceuticals Inc. | 0.06% | 176,479 | $167K | Reduce -87.5% |
| PEPG Pepgen Inc. | 0.06% | 150,000 | $167K | No change |
| JSPR Jasper Therapeutics Inc. | 0.05% | 25,107 | $139K | No change |
| KPTI Karyopharm Therapeutics Inc. | 0.04% | 27,257 | $117K | No change |
| MGNX Macrogenics Inc. | 0.03% | 80,071 | $97K | No change |
| SGMT Sagimet Biosciences Inc. Class A | 0.03% | 11,984 | $91K | No change |
| AIRS Airsculpt Technologies Inc. | 0.03% | 17,951 | $87K | New |
| SPRB Spruce Biosciences Inc. | 0.02% | 1,000,000 | $73K | No change |
| TKNO Alpha Teknova Inc. | 0.02% | 14,008 | $69K | No change |
| HOOK Hookipa Pharma Inc. | 0.02% | 52,996 | $67K | No change |
| TOVX Theriva Biologics Inc. | 0.02% | 120,031 | $52K | No change |
| TRAW Traws Pharma Inc. | 0.01% | 28,493 | $42K | No change |
| AUTONOMIX MED INC | 0.01% | 20,000 | $31K | No change |
| SYBX Synlogic Inc. | 0.01% | 20,422 | $26K | No change |
| RLMD Relmada Therapeutics Inc. | 0.01% | 40,270 | $24K | No change |
| NMRA Neumora Therapeutics Inc. | 0.00% | 12,498 | $9K | Reduce -19.1% |
Options reported separately and not counted above: CDTX puts ($24.4M), RARE calls ($20.5M), SLNO calls ($16.8M), SLNO puts ($16.8M), CDTX calls ($15.6M), CAPR puts ($13.5M), UNIQURE NV calls ($11.2M), RARE puts ($10.9M), PRAX calls ($10.2M), VKTX calls ($9.3M), MLTX puts ($9.2M), CAPR calls ($7.0M), and 18 more.
Portfolio Sells Q1 2025 → Q2 2025
| TARS Tarsus Pharmaceuticals Inc. | Reduce -59.5% | 2.63% | −5.48 |
| SPY SS SPDR S&P 500 ETF Trust-US | Sold out | 0.00% | −4.56 |
| BPMC Blueprint Medicines Corp. | Sold out | 0.00% | −3.28 |
| RARE Ultragenyx Pharmaceutical Inc. | Sold out | 0.00% | −2.56 |
| EWTX Edgewise Therapeutics Inc. | Sold out | 0.00% | −2.01 |
| SRRK Scholar Rock Holding Corp. | Reduce -79.9% | 0.58% | −1.98 |
| ELVN Enliven Therapeutics Inc. | Sold out | 0.00% | −1.86 |
| CRNX Crinetics Pharmaceuticals Inc. | Reduce -17.2% | 4.12% | −1.60 |
| TRVI Trevi Therapeutics Inc. | Sold out | 0.00% | −1.18 |
| BBIO Bridgebio Pharma Inc. | Sold out | 0.00% | −1.02 |
| KROS Keros Therapeutics Inc. | Sold out | 0.00% | −0.91 |
| ABEO Abeona Therapeutics Inc. | Sold out | 0.00% | −0.83 |
| EOLS Evolus Inc. | Sold out | 0.00% | −0.76 |
| MTSR Metsera Inc. | Reduce -48.5% | 0.73% | −0.60 |
| VERV Verve Therapeutics Inc. | Sold out | 0.00% | −0.53 |
| RCKT Rocket Pharmaceuticals Inc. | Sold out | 0.00% | −0.48 |
| TECX Tectonic Therapeutic Inc. | Reduce -39.2% | 1.08% | −0.48 |
| CPRX Catalyst Pharmaceuticals Inc. | Reduce -16.0% | 1.51% | −0.47 |
| AVTX Avalo Therapeutics Inc. | Reduce -82.3% | 0.06% | −0.46 |
| HELP Cybin Inc. | Reduce -64.6% | 0.39% | −0.43 |
| TDOC Teladoc Health Inc. | Sold out | 0.00% | −0.39 |
| CPIX Cumberland Pharmaceuticals | Reduce -19.5% | 0.66% | −0.36 |
| OKUR Onkure Therapeutics Inc. Class A | Sold out | 0.00% | −0.36 |
| NKTR Nektar Therapeutics | Sold out | 0.00% | −0.35 |
| ORKA Oruka Therapeutics Inc. | Reduce -60.8% | 0.25% | −0.33 |
| SLDB Solid Biosciences Inc. | Sold out | 0.00% | −0.28 |
| ETNB 89BIO Inc. | Sold out | 0.00% | −0.24 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -2.4% | 0.90% | −0.24 |
| OLMA Olema Pharmaceuticals Inc. | Sold out | 0.00% | −0.24 |
| GPCR Structure Therapeutics Inc. | Reduce -30.7% | 1.26% | −0.23 |
| GLUE Monte Rosa Therapeutics Inc. | Sold out | 0.00% | −0.21 |
| TERN Terns Pharmaceuticals Inc. | Reduce -81.0% | 0.07% | −0.21 |
| CHANNEL THERAPEUTICS CORPORA | Sold out | 0.00% | −0.20 |
| TGTX TG Therapeutics Inc. | Reduce -0.1% | 2.50% | −0.20 |
| PYXS Pyxis Oncology Inc. | Sold out | 0.00% | −0.20 |
| SWTX Springworks Therapeutics Inc. | Sold out | 0.00% | −0.18 |
| SGMOQ Sangamo Therapeutics Inc. | Reduce -32.3% | 0.23% | −0.17 |
| LXRX Lexicon Pharmaceuticals Inc. | Reduce -87.5% | 0.06% | −0.16 |
| ITOS Iteos Therapeutics Inc. | Sold out | 0.00% | −0.15 |
| THRD Third Harmonic Bio Inc. | Sold out | 0.00% | −0.11 |
| DNA Ginkgo Bioworks Holdings Inc. | Sold out | 0.00% | −0.11 |
| TYRA Tyra Biosciences Inc. | Sold out | 0.00% | −0.11 |
| MAZE Maze Therapeutics Inc. | Reduce -18.6% | 1.07% | −0.09 |
| ALLK Allakos LLC | Sold out | 0.00% | −0.09 |
| ACRS Aclaris Therapeutics Inc. | Sold out | 0.00% | −0.08 |
| MNPR Monopar Therapeutics Inc. | Sold out | 0.00% | −0.07 |
| CLYM Climb Bio Inc. | Sold out | 0.00% | −0.07 |
| VIGL Vigil Neuroscience Inc. | Reduce -87.5% | 0.08% | −0.06 |
| ELEV Elevation Oncology Inc. | Sold out | 0.00% | −0.06 |
| STIM Neuronetics Inc. | Reduce -0.0% | 1.27% | −0.05 |
Portfolio Buys Q1 2025 → Q2 2025
| CDTX Cidara Therapeutics Inc. | Add +86.6% | 7.49% | +5.74 |
| INSM Insmed Inc. | Add +93.1% | 5.45% | +3.35 |
| APGE Apogee Therapeutics Inc. | New | 3.33% | +3.33 |
| ALNY Alnylam Pharmaceuticals Inc. | Add +79.1% | 6.11% | +3.33 |
| COGT Cogent Biosciences Inc. | New | 2.46% | +2.46 |
| PRAX Praxis Precision Medicines I | Add +90.3% | 3.85% | +2.06 |
| VRNA Verona Pharma Ltd. | Add +12.9% | 4.59% | +1.91 |
| ARVN Arvinas Inc. | Add +269.7% | 2.07% | +1.54 |
| JAZZ Jazz Pharmaceuticals PLC | New | 1.40% | +1.40 |
| CGON CG Oncology Inc. | New | 1.33% | +1.33 |
| NAMS Newamsterdam Pharma Co. NV | New | 1.24% | +1.24 |
| DCTH Delcath Systems Inc. | Add +221.2% | 1.45% | +1.03 |
| BIIB Biogen Inc. | New | 0.89% | +0.89 |
| PCVX Vaxcyte Inc. | Add +52.5% | 3.28% | +0.82 |
| FULC Fulcrum Therapeutics Inc. | Add +114.2% | 0.98% | +0.79 |
| KALV Kalvista Pharmaceuticals Inc. | New | 0.74% | +0.74 |
| GERN Geron Corp. | Add +966.7% | 0.75% | +0.67 |
| CYTK Cytokinetics Inc. | Add +55.7% | 2.55% | +0.59 |
| PRQR Proqr Therapeutics NV | New | 0.59% | +0.59 |
| QURE Uniqure NV | New | 0.55% | +0.55 |
| VKTX Viking Therapeutics Inc. | Add +100.0% | 0.88% | +0.48 |
| SLN Silence Therapeutics PLC-ADR | New | 0.46% | +0.46 |
| WVE Wave Life Sciences Ltd. | New | 0.35% | +0.35 |
| IBB iShares Biotechnology ETF | New | 0.24% | +0.24 |
| IFRX Inflarx NV | New | 0.18% | +0.18 |
| VYNE THERAPEUTICS INC | New | 0.16% | +0.16 |
| NYXH Nyxoah SA | New | 0.13% | +0.13 |
| ANAB Anaptysbio Inc. | New | 0.12% | +0.12 |
| VERA Vera Therapeutics Inc. | New | 0.11% | +0.11 |
| ZYME Zymeworks Inc. | New | 0.10% | +0.10 |
| IMTX Immatics NV | New | 0.09% | +0.09 |
| AIRS Airsculpt Technologies Inc. | New | 0.03% | +0.03 |
| DYN Dyne Therapeutics Inc. | Add +1.4% | 1.15% | −0.08 |
| SRPT Sarepta Therapeutics Inc. | Add +165.6% | 2.54% | −0.97 |
Options Activity Q1 2025 → Q2 2025
| SPY SS SPDR S&P 500 ETF Trust-US | put | Sold out | 320,000 | $179.0Mbefore exit |
| LLY Eli Lilly & Co. | put | Sold out | 150,000 | $123.9Mbefore exit |
| CORT Corcept Therapeutics Inc. | put | Sold out | 287,900 | $32.9Mbefore exit |
| CDTX Cidara Therapeutics Inc. | put | New | 501,600 | $24.4M |
| BBIO Bridgebio Pharma Inc. | call | Sold out | 655,400 | $22.7Mbefore exit |
| RARE Ultragenyx Pharmaceutical Inc. | call | Add +397.9% | 563,100 | $20.5M |
| SLNO Soleno Therapeutics Inc. | put | Add +100.0% | 200,000 | $16.8M |
| SLNO Soleno Therapeutics Inc. | call | Reduce -17.7% | 200,000 | $16.8M |
| CDTX Cidara Therapeutics Inc. | call | New | 321,000 | $15.6M |
| CAPR Capricor Therapeutics Inc. | put | New | 1,360,200 | $13.5M |
| CORT Corcept Therapeutics Inc. | call | Sold out | 100,000 | $11.4Mbefore exit |
| UNIQURE NV | call | New | 800,000 | $11.2M |
| RARE Ultragenyx Pharmaceutical Inc. | put | Add +200.0% | 300,000 | $10.9M |
| PRAX Praxis Precision Medicines I | call | New | 242,400 | $10.2M |
| VKTX Viking Therapeutics Inc. | call | Add +133.3% | 350,000 | $9.3M |
| MLTX Moonlake Immunotherapeutics | put | Add +105.8% | 194,500 | $9.2M |
| RNAM Avidity Biosciences Inc. | put | Sold out | 300,000 | $8.9Mbefore exit |
| BHVN Biohaven Ltd. | call | Sold out | 348,200 | $8.4Mbefore exit |
| TRUP Trupanion Inc. | call | Sold out | 200,000 | $7.5Mbefore exit |
| ACLX Arcellx Inc. | put | Sold out | 111,600 | $7.3Mbefore exit |
| CAPR Capricor Therapeutics Inc. | call | Add +75.0% | 700,000 | $7.0M |
| IMVT Immunovant Inc. | put | Sold out | 400,000 | $6.8Mbefore exit |
| SRPT Sarepta Therapeutics Inc. | call | New | 332,100 | $5.7M |
| CYTK Cytokinetics Inc. | call | New | 150,000 | $5.0M |
| PTGX Protagonist Therapeutics Inc. | put | Sold out | 100,000 | $4.8Mbefore exit |
| PTGX Protagonist Therapeutics Inc. | call | Sold out | 100,000 | $4.8Mbefore exit |
| KALV Kalvista Pharmaceuticals Inc. | call | New | 400,000 | $4.5M |
| BIOHAVEN LTD | call | New | 300,000 | $4.2M |
| FULC Fulcrum Therapeutics Inc. | call | New | 534,000 | $3.7M |
| INCY Incyte Corp. | call | Sold out | 60,400 | $3.7Mbefore exit |
| VERA Vera Therapeutics Inc. | call | New | 153,200 | $3.6M |
| APGE Apogee Therapeutics Inc. | put | Add +11.9% | 79,100 | $3.4M |
| ALT Altimmune Inc. | call | New | 827,500 | $3.2M |
| QURE Uniqure NV | call | Sold out | 300,000 | $3.2Mbefore exit |
| KYMR Kymera Therapeutics Inc. | call | Sold out | 100,000 | $2.7Mbefore exit |
| CNTA Centessa Pharmaceuticals Ltd. | call | New | 200,000 | $2.6M |
| AKRO Akero Therapeutics Inc. | call | New | 44,400 | $2.4M |
| DYN Dyne Therapeutics Inc. | call | Sold out | 187,000 | $2.0Mbefore exit |
| COGT Cogent Biosciences Inc. | call | New | 262,600 | $1.9M |
| ARCT Arcturus Therapeutics Holdin | call | Sold out | 150,000 | $1.6Mbefore exit |
| HROW Harrow Inc. | call | Sold out | 58,300 | $1.6Mbefore exit |
| TRUP Trupanion Inc. | put | Sold out | 40,000 | $1.5Mbefore exit |
| CMPX Compass Therapeutics Inc. | call | Sold out | 662,200 | $1.3Mbefore exit |
| CMPX Compass Therapeutics Inc. | put | Sold out | 662,200 | $1.3Mbefore exit |
| ALT Altimmune Inc. | put | Sold out | 240,000 | $1.2Mbefore exit |
| CRVS Corvus Pharmaceuticals Inc. | call | Sold out | 338,100 | $1.1Mbefore exit |
| IMUX Immunic Inc. | call | Sold out | 635,800 | $693Kbefore exit |
| IRON Disc Medicine Inc. | call | Sold out | 11,900 | $591Kbefore exit |
| MLYS Mineralys Therapeutics Inc. | call | Sold out | 34,300 | $545Kbefore exit |
| KYMR Kymera Therapeutics Inc. | put | Reduce -94.3% | 10,000 | $436K |
Showing the first 50 of 57.
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 126 | $610.9M | ABVX, KOD, ALMS, PRAX, PCVX |
| Q1 2026 | 127 | $699.0M | TERN, KOD, ALMS, PCVX, PRAX |
| Q4 2025 | 135 | $772.6M | TERN, CDTX, ABVX, JAZZ, MAZE |
| Q3 2025 | 116 | $494.3M | GMAB, ABVX, IONS, CDTX, MAZE |
| Q2 2025 | 103 | $302.2M | CDTX, ALNY, INSM, VRNA, CRNX |
| Q1 2025 | 116 | $306.9M | TARS, CRNX, SPY, SRPT, BPMC |
| Q4 2024 | 122 | $350.2M | TARS, CRNX, SRRK, BPMC, FBRX |
| Q3 2024 | 96 | $322.0M | TARS, CRNX, ELVN, RCUS, VRDN |
| Q2 2024 | 85 | $320.5M | SRPT, CRNX, TARS, SLNO, CRBP |
| Q1 2024Amended | 82 | $367.7M | CRNX, TARS, SLNO, CRBP, SRPT |